Oxford Drug Design recently attended an event at the Said Buisness School, in Oxford showcasing the latest developments of Collaborative Drug Discovery’s compound informatics system and ELN.

Dr Michael Charlton spoke about our antibacterial projects and how Oxford Drug Design are integrating the collaborative features of CDD into our workflow.